GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $227,000 | +6.6% | 5,322 | 0.0% | 0.19% | +4.4% |
| Q2 2019 | $213,000 | -4.1% | 5,322 | 0.0% | 0.18% | -9.5% |
| Q1 2019 | $222,000 | +7.8% | 5,322 | -1.4% | 0.20% | +6.4% |
| Q4 2018 | $206,000 | -8.0% | 5,395 | -3.1% | 0.19% | 0.0% |
| Q3 2018 | $224,000 | 0.0% | 5,565 | 0.0% | 0.19% | -4.1% |
| Q2 2018 | $224,000 | +3.2% | 5,565 | 0.0% | 0.20% | -0.5% |
| Q1 2018 | $217,000 | – | 5,565 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |